Louveau B. et al.
Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor.
ESMO Open. (2017) Jun. 2(2):e000173.
doi: 10.1136/esmoopen-2017-000173
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Louveau B. et al.
Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor.
ESMO Open. (2017) Jun. 2(2):e000173.
doi: 10.1136/esmoopen-2017-000173